DNB // Back Bay

A unique integrated strategy and corporate and investment banking solution for global and emerging life science and healthcare companies.

The DNB // Back Bay Partnership fortifies companies with financial strategic guidance on growth opportunities across sector and development stage—from private and emerging public life science and healthcare companies seeking partnering, licensing opportunities, M&A opportunities and listing support and execution on U.S. and Nordic exchanges to consolidators seeking and executing on acquisitions and other growth strategies.

We match strategic guidance and capital to develop healthcare assets across the continuum of development within global biopharma, medtech, healthtech and life science companies at every stage and sector.

Press release about the partnership

About the Partnership

The DNB // Back Bay Partnership was formalized in 2023 to provide healthcare companies with strategic guidance, M&A, and partnering support and execution and capabilities in global capital markets and investment and commercial banking. DNB headquartered in Oslo, Norway, and Back Bay Life Science Advisors, headquartered in Boston, Massachusetts, are recognized leaders in global life science development and banking. Together, DNB and Back Bay Life Science Advisors offer unique support to companies along the full continuum of life science and healthcare development.

About

DNB is Norway’s largest financial institution and leading corporate and investment bank, with international expertise in corporate banking and public capital markets across selected industry sectors, specializing in arranging financing for healthcare companies globally.

DNB has been established in North America since 1975, with a full service branch in New York that serves corporate customers in the bank’s strategic business areas. A full range of wholesale investment banking services is provided by DNB Markets, Inc., a U.S. registered broker-dealer and wholly owned subsidiary of DNB Bank ASA in New York, established in 2003.

Back Bay Life Science Advisors (Back Bay) provides life science strategy and investment banking guidance and execution to global life science companies and their investors. Back Bay’s integrated strategy and banking teams advise companies on all aspects of life science, healthcare technology and drug development, including planning an initial concept, product commercialization, franchise growth, licensing, partnering, M&A, divestiture and more.

With a strong presence in Europe and the Nordic markets and a global reach, Back Bay has guided hundreds of healthcare companies through the complexities of commercial development and transactions. Every project and transaction is rooted in Back Bay’s deep expertise in life science, healthcare industry strategy and investment banking. Learn more:www.bblsa.com

Partnership Capabilities/Offerings

Strategic advice based on nuanced understanding of the clinical and scientific foundations of new therapeutics and medical technologies, expertise in business and financial markets, and knowledge of what makes successful R&D, commercialization and transactions. The Partnership provides actionable strategies for product development, commercial success and transactional execution to drive growth and investment returns

The DNB // Back Bay Partnership is comprised of dedicated multidisciplinary teams of healthcare experts and corporate and investment bankers who understand the complete picture of asset and company development.

Project Leadership Includes

Jonathan P. Gertler
Location: Boston
Send email
Co-Founder, Managing Partner & CEO, Back Bay Life Science Advisors
Daniel M. Hochstadt
Location: New York
Send email
Managing Director, Head of Investment Banking Americas, DNB Markets Inc.
Thomas Hoftvedt
Location: Oslo
Send email
Global Head of Healthcare, DNB Markets IBD
Thomas Tangen
Location: New York
Send email
Head of Healthcare USA, DNB Corporate Banking

DNB // Back Bay

About the Partnership

About

Partnership Capabilities/Offerings

Project Leadership Includes

Jonathan P. Gertler

Daniel M. Hochstadt

Thomas Hoftvedt

Thomas Tangen